Diabetes Treatment Denied in Massachusetts

Massachusetts has some of the strongest health insurance consumer protections in the United States, along with near-universal coverage through the Commonwealth Connector (the original model for the ACA). Despite this, insurance denials for diabetes treatments — including continuous glucose monitors, insulin pumps, and GLP-1 medications like Ozempic and Mounjaro — remain common. Massachusetts patients have powerful appeal rights, and knowing how to use them is essential.

The Massachusetts Insurance Landscape for Diabetes

Major health insurers in Massachusetts include Blue Cross Blue Shield of Massachusetts (BCBSMA), Tufts Health Plan (Point32Health), Harvard Pilgrim Health Care (Point32Health), Health New England, Fallon Health, and UnitedHealthcare. Massachusetts has a competitive managed care market with strong regional carriers. The Massachusetts Health Connector operates the state's ACA marketplace.

The Massachusetts Division of Insurance (DOI) and the Office of Patient Protection (OPP) regulate fully insured plans in the state. Massachusetts has enacted some of the most comprehensive health insurance mandates in the country, and its regulatory agencies are responsive to consumer complaints.

Massachusetts's Insulin Cost-Cap Law and Diabetes Mandates

Massachusetts enacted an insulin cost-cap law capping patient out-of-pocket costs for insulin at $35 per 30-day supply for state-regulated plans. Beyond the insulin cap, Massachusetts law requires state-regulated plans to cover diabetes management equipment, supplies, and education as essential benefits. The state has also enacted step therapy exception requirements that apply to diabetes medications.

Medicaid (MassHealth) and Diabetes

MassHealth, Massachusetts's Medicaid program, is widely regarded as one of the most comprehensive state Medicaid programs in the country. MassHealth covers insulin, oral diabetes medications, CGMs, blood glucose monitors, test strips, insulin pumps, and diabetes self-management education. CGM coverage has been expanded significantly, and the barriers to access are lower than in most other states.

If your MassHealth plan denied a diabetes treatment, file an appeal directly with MassHealth at 617-847-3302 or through the MassHealth online portal. You can also request a Fair Hearing through the Division of Administrative Law Appeals (DALA).

Common Denials in Massachusetts

GLP-1 Drugs (Ozempic, Mounjaro, Victoza, Saxenda): BCBSMA and Harvard Pilgrim apply step therapy for GLP-1 agonists, requiring failure of metformin and often one additional agent. Massachusetts's step therapy exception law (M.G.L. c. 176X) requires insurers to grant exceptions within 72 hours of a request when a clinician certifies that step therapy is clinically inappropriate. Reference this statute explicitly in your exception request.

CGMs: Massachusetts has stronger CGM coverage requirements than most states. Denials typically occur when patients are on Type 2 management without insulin. The most effective strategy is a physician certification citing the ADA Standards of Care and documenting hypoglycemia risk or glycemic variability.

Insulin Pumps: BCBSMA and Tufts Health Plan have specific pump criteria that often require A1C documentation and proof of MDI failure. An endocrinologist's detailed letter explaining the clinical superiority of pump therapy for this specific patient is the most persuasive tool.

Formulary Non-Preferred Drug Denials: Massachusetts insurers place some newer diabetes drugs on high-cost tiers. Request a formulary exception, which requires the insurer to approve a non-formulary or non-preferred drug when the preferred alternative is clinically inferior or contraindicated.

How to Appeal a Diabetes Denial in Massachusetts

1. Request the denial notice with the specific reason and criteria the insurer applied. Massachusetts law requires this to be provided in writing.
2. Have your physician write a detailed letter of medical necessity citing M.G.L. provisions on step therapy exception, the ADA Standards of Care, and your individual clinical history.
3. File an internal appeal within 30 days of the denial (note: Massachusetts has a shorter internal appeal window for some plan types). The insurer must respond within 30 days for standard appeals.
4. Request External Independent Review: Complete Guide" class="auto-link">external review through the Massachusetts Division of Insurance if the internal appeal fails. Massachusetts has an accessible external review process administered by the DOI, and independent reviewers frequently overturn denials when clinical documentation is strong.
5. File a complaint with the Massachusetts Division of Insurance at 1-877-563-4467 or mass.gov/doi, or with the Office of Patient Protection for managed care plan issues.

State Insurance Department Contact

Massachusetts Division of Insurance (DOI)

• Consumer Hotline: 1-877-563-4467
• Website: mass.gov/doi

Massachusetts Office of Patient Protection (OPP)

• Phone: 617-521-1400
• Website: mass.gov/masshealth (for MassHealth)

Additional Resources

The American Diabetes Association (diabetes.org) provides Massachusetts-specific resources and appeal templates. The Health Law Advocates (healthlawadvocates.org) in Boston provides free legal assistance to Massachusetts residents facing insurance coverage disputes, including diabetes treatment denials.

Massachusetts's regulatory environment is among the most favorable in the country for patients challenging insurance denials. Take advantage of it. File your appeals promptly, engage your physician, and use the state's external review process if the internal appeal fails.

Fight Back With ClaimBack

ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.

Fight your denial at ClaimBack →

Related Reading:

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• What Is Step Therapy?